HIV-HCV Co-infection therapeutic outcomes have not improved over time

HIV Clin Trials. 2009 May-Jun;10(3):203-6. doi: 10.1310/hct1003-203.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Antiretroviral Therapy, Highly Active* / adverse effects
  • Antiretroviral Therapy, Highly Active* / methods
  • Female
  • HIV Infections / complications
  • HIV Infections / drug therapy*
  • HIV Infections / virology
  • HIV Protease Inhibitors / adverse effects
  • HIV Protease Inhibitors / therapeutic use*
  • Hepatitis C / complications
  • Hepatitis C / drug therapy*
  • Hepatitis C / virology
  • Humans
  • Male
  • Medication Adherence
  • Middle Aged
  • Reverse Transcriptase Inhibitors / adverse effects
  • Reverse Transcriptase Inhibitors / therapeutic use*
  • Treatment Outcome
  • Viral Load
  • Young Adult

Substances

  • HIV Protease Inhibitors
  • Reverse Transcriptase Inhibitors